The addition of glucagon receptor agonism is intended to further increase energy expenditure and fat breakdown, though this requires confirmation in Phase 3 trials
Normally, GHK-Cu's collagen-stimulating effects outweigh this degradation
CBO notes that some analyses of weight loss via GLP-1s found they reduced all-cause mortality in certain patients, while other methods had mixed results notably bariatric surgery, which did not clearly lower future health spending and was heavily dependent on individual adherence to post-surgery lifestyle changes
With ultra-fast action and absorption, this supplement is indicated for abdominal definition, reduction of body fat and to facilitate recovery after exercise
Clinical studies have used GHK-Cu at concentrations ranging from 0.01% to 1%, with most effective topical products formulated between 0.05% and 0.5%
It most frequently affects the first digit of the hands and feet and is usually associated with a distal phalanx shorter than normal
